Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Cancer Immunol Res. 2015 Oct 13;4(1):61–71. doi: 10.1158/2326-6066.CIR-15-0055

Figure 3. ASCT does not alter T cell expression of inhibitory receptors.

Figure 3

PBMCs were analyzed by flow cytometry for expression of the inhibitory receptors CTLA-4 (A), PD-1 (B), LAG-3 (C), and TIM-3 (D) on CD4+ and CD8+ T cells before (white bar), and 3-months (gray bar) and 12-months (black bar) after ASCT. Pooled data (mean ± SD) from 10 patients are shown.